THAR
THAR
NASDAQ · Biotechnology

Tharimmune Inc

$4.14
+0.21 (+5.34%)
As of Feb 8, 2:07 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +619.3% upside
Low Target $19.47
Average Target $29.78
High Target $34.67
Current Price $4.14
Current
$4.14
Target
$29.78
$19.47 $29.78 avg $34.67
Scenario Analysis
Bear Case
$19.47
370.3%
Low target
Base Case
$29.78
+619.3%
Avg target
Bull Case
$34.67
+737.4%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$29.52
-86.0% from high
52-Week Low
$22.62
+-81.7% from low
Target vs 52W High
$29.78
+0.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%